APA

Krassas G. E., Pontikides N., Doukidis D., Heufelder G. & Heufelder A. E. (20020916). Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues. : Thyroid : official journal of the American Thyroid Association.

Chicago

Krassas G E, Pontikides N, Doukidis D, Heufelder G and Heufelder A E. 20020916. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues. : Thyroid : official journal of the American Thyroid Association.

Harvard

Krassas G. E., Pontikides N., Doukidis D., Heufelder G. and Heufelder A. E. (20020916). Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues. : Thyroid : official journal of the American Thyroid Association.

MLA

Krassas G E, Pontikides N, Doukidis D, Heufelder G and Heufelder A E. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues. : Thyroid : official journal of the American Thyroid Association. 20020916.